ProQR Therapeutics N.V. (PRQR)

NCM – Real Time Price. Currency in USD

1.89

-0.03 (-1.56%)

Market open: Aug 12, 2026, 10:11 AM EDT

1.89

-0.03 (-1.56%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

18M

20M

Cost of goods sold

-3M

Gross Profit

15M

17M

Operating expenses (excl. COGS)

-64M

-51M

-42M

-70M

Operating Income

-50M

-34M

-38M

-69M

Non-operating income, total

Pretax income

-48M

-30M

-67M

Equity in earnings

-8K

Taxes

-21K

213K

84K

-101K

Non-controlling/minority interest

-415K

-231K

After tax other income/expense

Net income before discontinued operations

-48M

-30M

-68M

Discontinued operations

Net income

-48M

-30M

-68M

Dilution adjustment

Preferred dividends

ProQR Therapeutics N.V. (PRQR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ProQR Therapeutics N.V. (PRQR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

ProQR Therapeutics N.V. (PRQR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ProQR Therapeutics N.V. (PRQR)

Income Statement (Annual)

Income Statement (Annual)